Fideuram Intesa Sanpaolo Private Banking S.P.A. Cuts Stake in Cigna Group $CI

Fideuram Intesa Sanpaolo Private Banking S.P.A. lessened its stake in shares of Cigna Group (NYSE:CI) by 21.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,411 shares of the health services provider’s stock after selling 2,594 shares during the period. Fideuram Intesa Sanpaolo Private Banking S.P.A.’s holdings in Cigna Group were worth $2,510,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Heritage Investors Management Corp increased its stake in Cigna Group by 3.1% during the 1st quarter. Heritage Investors Management Corp now owns 17,780 shares of the health services provider’s stock worth $4,743,000 after buying an additional 537 shares in the last quarter. Physician Wealth Advisors Inc. lifted its position in shares of Cigna Group by 2.6% in the first quarter. Physician Wealth Advisors Inc. now owns 2,737 shares of the health services provider’s stock valued at $730,000 after acquiring an additional 70 shares in the last quarter. Pzena Investment Management LLC boosted its stake in shares of Cigna Group by 1.3% in the first quarter. Pzena Investment Management LLC now owns 578,448 shares of the health services provider’s stock worth $154,301,000 after acquiring an additional 7,615 shares during the last quarter. Center for Wealth Management Advisory acquired a new stake in shares of Cigna Group in the first quarter worth approximately $1,698,000. Finally, Root Financial Partners LLC increased its position in shares of Cigna Group by 42.6% during the first quarter. Root Financial Partners LLC now owns 669 shares of the health services provider’s stock worth $178,000 after purchasing an additional 200 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

NYSE CI opened at $287.50 on Friday. The stock’s fifty day moving average is $285.09 and its two-hundred day moving average is $279.24. The firm has a market capitalization of $76.05 billion, a P/E ratio of 12.19, a price-to-earnings-growth ratio of 1.11 and a beta of 0.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $323.10.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period last year, the company earned $6.74 EPS. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on CI shares. Cantor Fitzgerald increased their price objective on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a report on Friday, May 1st. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. The Goldman Sachs Group raised their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Wolfe Research restated an “outperform” rating and set a $315.00 price target on shares of Cigna Group in a research report on Tuesday, June 16th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $338.30.

Insider Activity

In other news, CEO David Cordani sold 201,878 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by company insiders.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.